DRD1 and drug-induced dyskinesia: The attenuation of dyskinetic behavior and striatal FosB expression by TMS could indicate that this intervention disrupted the activation of D1R-containing cells, since D1R blockade abolishes FosB signaling [11] and the reduction in FosB transcriptional activity mitigates the severity of dyskinesias [10,48].